Tri-methyl BSA Competitive Inhibitor

<strong>Tri-methyl BSA Competitive Inhibitor</strong>_x000D_ <strong>Catalog number:</strong> B2015690_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Tri-methyl BSA Competitive Inhibitor_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Li Y, Yang B, Miao H, Liu L, Wang Z, Jiang C, Yang Y, Qiu S, Li X, Geng Y, Zhang Y, Liu Y. Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma Hepatology. 2023 Nov 1;78(5):1352-1367._x000D_ 2: Yang GJ, Zhu MH, Lu XJ, Liu YJ, Lu JF, Leung CH, Ma DL, Chen J. The emerging role of KDM5A in human cancer J Hematol Oncol. 2021 Feb 17;14(1):30._x000D_ 3: Chen LJ, Xu XY, Zhong XD, Liu YJ, Zhu MH, Tao F, Li CY, She QS, Yang GJ, Chen J. The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy Bioorg Chem. 2023 Apr;133:106409._x000D_ 4: Van der Meulen J, Speleman F, Van Vlierberghe P. The H3K27me3 demethylase UTX in normal development and disease Epigenetics. 2014 May;9(5):658-68._x000D_ 5: Tsai HI, Wu Y, Huang R, Su D, Wu Y, Liu X, Wang L, Xu Z, Pang Y, Sun C, He C, Shu F, Zhu H, Wang D, Cheng F, Huang L, Chen H. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia Acta Pharm Sin B. 2022 Apr;12(4):1913-1927._x000D_ 6: Unoki M, Brunet J, Mousli M. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis Biochem Pharmacol. 2009 Nov 15;78(10):1279-88._x000D_ 7: Cao L, Yang Y, Ye Z, Lin B, Zeng J, Li C, Liang T, Zhou K, Li J. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways Int J Mol Med. 2018 Sep;42(3):1625-1636._x000D_ 8: Chen H, Huang Y, Zhu X, Liu C, Yuan Y, Su H, Zhang C, Liu C, Xiong M, Qu Y, Yun P, Zheng L, Huang K. Histone demethylase UTX is a therapeutic target for diabetic kidney disease J Physiol. 2019 Mar;597(6):1643-1660._x000D_ 9: Duan L, Perez RE, Chastain PD 2nd, Mathew MT, Bijukumar DR, Maki CG. JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells Oncogene. 2019 Jul;38(28):5643-5657._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31487061">10: Adamik J, Pulugulla SH, Zhang P, Sun Q, Lontos K, Macar DA, Auron PE, Galson DL. EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets J Bone Miner Res. 2020 Jan;35(1):181-195. </a>_x000D_ _x000D_ <strong>Products Related to Tri-methyl BSA Competitive Inhibitor can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>